MedPath

Feasibility of adding Hydrogen gas inhalation to relieve the acute toxicities from concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)

Phase 2
Conditions
Concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC) induced acute toxicities.
Hydrogen gas, Hydrogen gas Inhalation, Concurrent chemoradiotherapy, CCRT, Locally advanced head and neck cancer, Acute toxicities
Registration Number
TCTR20230627002
Lead Sponsor
Faculty of Medicine, Chiang Mai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
10
Inclusion Criteria

1. Loco-regional advanced stage HNC
2. Histologically-proven diagnosis of HNC
3. Eastern Cooperative Oncology Group (ECOG) performance status 0-2
4. Able to provide informed consent

Exclusion Criteria

1. Distant metastasis or locoregional recurrence disease
2. Contraindications to RT or chemotherapy or Hydrogen gas inhalation
3. Previous head and neck irradiation
4. Previous head and neck surgery (except biopsy)
5. Patients with tracheostomy tube
6. Patients with respiratory disease e.g. asthma, COPD, Pneumonia, Lung cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath